IP Library Assignment 065314/0430
Patent Assignment
Reel/Frame 065314/0430

Merger

Recorded: 2023-10-23 Pages: 16
Assignor
SUMITOMO PHARMA ONCOLOGY, INC.
Executed: 2023-09-15
Assignee
SUMITOMO PHARMA AMERICA, INC.
84 WATERFORD DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752
Covered Properties (4)
JAK2 and ALK2 Inhibitors and Methods for Their Use
Application: 14/776,392 →
Publication: US 2016/0214944
JAK2 and ALK2 Inhibitors and Methods for Their Use
Application: 16/226,605 →
Publication: US 2019/0119221
JAK2 and ALK2 Inhibitors and Methods for Their Use
Application: 16/930,261 →
Publication: US 2021/0070715
JAK2 and ALK2 Inhibitors and Methods for Their Use
Application: 18/320,863 →
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 22, 2016
From: MOLLARD, ALEXIS; WARNER, STEVEN L.; FLYNN, GARY A.; VANKAYALAPATI, HARIPRASAD
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 038068/0314 →
Security Interest Nov 17, 2016
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 040362/0884 →
Assignment of Assignor's Interest Jun 30, 2020
From: MOLLARD, ALEXIS; WARNER, STEVEN L.; FLYNN, GARY A.; VANKAYALAPATI, HARIPRASAD
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053091/0872 →
Merger Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0344 →
Change of Name Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0663 →
Assignment of Assignor's Interest Jul 22, 2020
From: MOLLARD, ALEXIS; WARNER, STEVEN L.; FLYNN, GARY A.; VANKAYALAPATI, HARIPRASAD
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053280/0305 →
Merger Jul 22, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053280/0359 →
Change of Name Jul 22, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053283/0243 →
Change of Name Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →